In an effort to standardize practice, the European Confederation of Medical Mycology
(ECMM) developed the European Confederation of Medical Mycology Quality of Clinical …

Invasive fungal infections pose a substantial threat to patients in healthcare settings globally.
Recent changes in the prevalence of fungal species and challenges in conducting reference …

Abstract Objective Usually, 7–20% of preterm neonates colonized by Candida species
present invasive candidiasis. Candida albicans, and several non-albicans species cause …

Recent changes in the occurrence of fungal species and the difficulties in performing
reference antifungal susceptibility testing highlight the importance of surveillance of fungal …

Candidemia is a major cause of morbidity and mortality in health care settings, and its
epidemiology is changing. In the last two decades, the proportion of non-albicans Candida …

Background: The WHO fungal priority list classifies Candida species as critical and high-
priority pathogens, and the WHO GLASS fungi initiative seeks to establish a standardised …

Recognising the growing global burden of fungal infections, the World Health Organization
(WHO) established an advisory group consisting of experts in fungal diseases to develop a …

Ibrexafungerp (IBX) is a new antifungal drug that recently entered the antifungal landscape.
It disrupts fungal cell wall synthesis by non-competitive inhibition of the β-(1, 3)-D-glucan …

Objectives The applicability of a simple and high-throughput method for quantitative
characterization of biofilm formation by Candida boidinii was tested in order to evaluate the …

Sphingolipids are major constituents of the plasma membrane that can act as structural and
signalling molecules in diverse organisms such as animals, plants, and fungi. The …